OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brain and Systemic Inflammation in De Novo Parkinson's Disease
Talene A. Yacoubian, Yu-Hua Fang, Adam Gerstenecker, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 743-754
Open Access | Times Cited: 32
Talene A. Yacoubian, Yu-Hua Fang, Adam Gerstenecker, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 743-754
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
The heterogeneity of Parkinson’s disease
Ullrich Wüllner, Per Borghammer, Chi‐un Choe, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 827-838
Open Access | Times Cited: 65
Ullrich Wüllner, Per Borghammer, Chi‐un Choe, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 827-838
Open Access | Times Cited: 65
Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota
Qingxia Gan, Maoyao Peng, Haobo Wei, et al.
Food & Function (2024) Vol. 15, Iss. 6, pp. 2920-2938
Closed Access | Times Cited: 18
Qingxia Gan, Maoyao Peng, Haobo Wei, et al.
Food & Function (2024) Vol. 15, Iss. 6, pp. 2920-2938
Closed Access | Times Cited: 18
The immune system in Parkinson’s disease: what we know so far
Cintia Roodveldt, Liliana Bernardino, Özgür Öztop Çakmak, et al.
Brain (2024)
Open Access | Times Cited: 17
Cintia Roodveldt, Liliana Bernardino, Özgür Öztop Çakmak, et al.
Brain (2024)
Open Access | Times Cited: 17
Targeting mitophagy in neurodegenerative diseases
Odetta Antico, Paul Thompson, Nicholas T. Hertz, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 6
Odetta Antico, Paul Thompson, Nicholas T. Hertz, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 6
Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses
Tae Yoon Park, Jeha Jeon, Young Cha, et al.
Cell Research (2024) Vol. 34, Iss. 7, pp. 479-492
Open Access | Times Cited: 9
Tae Yoon Park, Jeha Jeon, Young Cha, et al.
Cell Research (2024) Vol. 34, Iss. 7, pp. 479-492
Open Access | Times Cited: 9
Neurotoxic effects of 2-ethylhexyl diphenyl phosphate exposure on zebrafish larvae: Insight into inflammation-driven changes in early motor behavior
Anyu Ni, Fang Lü, M Xi, et al.
The Science of The Total Environment (2024) Vol. 915, pp. 170131-170131
Closed Access | Times Cited: 8
Anyu Ni, Fang Lü, M Xi, et al.
The Science of The Total Environment (2024) Vol. 915, pp. 170131-170131
Closed Access | Times Cited: 8
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 8
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 8
Plasma fibronectin is a prognostic biomarker of disability in Parkinson’s disease: a prospective, multicenter cohort study
Shuzhen Zhu, Hualin Li, Zifeng Huang, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Shuzhen Zhu, Hualin Li, Zifeng Huang, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Neuroinflammation is linked to dementia risk in Parkinson’s disease
Antonina Kouli, Lennart R. B. Spindler, Tim D. Fryer, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 923-935
Open Access | Times Cited: 19
Antonina Kouli, Lennart R. B. Spindler, Tim D. Fryer, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 923-935
Open Access | Times Cited: 19
Executive dysfunction in Parkinson's disease: From neurochemistry to circuits, genetics and neuroimaging
Shuyan Tong, Ruiwen Wang, Hui‐Hua Li, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111272-111272
Closed Access
Shuyan Tong, Ruiwen Wang, Hui‐Hua Li, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111272-111272
Closed Access
Therapeutic Efficacy of Small Extracellular Vesicles Loaded with ROCK Inhibitor in Parkinson’s Disease
Candy Carbajal, Myosotys Rodriguez, Florida Owens, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 365-365
Open Access
Candy Carbajal, Myosotys Rodriguez, Florida Owens, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 365-365
Open Access
Impact of sex on neuroimmune contributions to Parkinson’s disease
Mélanie Bourque, Marc Morissette, Denis Soulet, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110668-110668
Open Access | Times Cited: 12
Mélanie Bourque, Marc Morissette, Denis Soulet, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110668-110668
Open Access | Times Cited: 12
Cytokine activity in Parkinson’s disease
Nicolas Dzamko
Neuronal Signaling (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 11
Nicolas Dzamko
Neuronal Signaling (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 11
Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions
Anna C. Stoll, Christopher J. Kemp, Joseph R. Patterson, et al.
Neurobiology of Disease (2024) Vol. 191, pp. 106411-106411
Open Access | Times Cited: 4
Anna C. Stoll, Christopher J. Kemp, Joseph R. Patterson, et al.
Neurobiology of Disease (2024) Vol. 191, pp. 106411-106411
Open Access | Times Cited: 4
From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches
Negar Ebadpour, Mahmoud Mahmoudi, Ramiar Kamal Kheder, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113015-113015
Closed Access | Times Cited: 4
Negar Ebadpour, Mahmoud Mahmoudi, Ramiar Kamal Kheder, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113015-113015
Closed Access | Times Cited: 4
Brain metabolites are associated with sleep architecture and cognitive functioning in older adults
Christina Mueller, Rodolphe Nenert, Corina Catiul, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 2
Christina Mueller, Rodolphe Nenert, Corina Catiul, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 2
Current insights and assumptions on α-synuclein in Lewy body disease
Rehana K. Leak, Rachel N. Clark, Muslim Abbas, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 2
Rehana K. Leak, Rachel N. Clark, Muslim Abbas, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 2
Study on the anti-Parkinson's disease activity mechanism and preparation of panaxadiol
Lei Xu, Zhongjin Zhang, Ziqi Feng, et al.
Phytomedicine (2024) Vol. 136, pp. 156296-156296
Closed Access | Times Cited: 2
Lei Xu, Zhongjin Zhang, Ziqi Feng, et al.
Phytomedicine (2024) Vol. 136, pp. 156296-156296
Closed Access | Times Cited: 2
Longitudinal TSPO PET imaging with [18F] DPA-714 in PPMI (PPMI DPA-714 PET Imaging) v1
David G. Standaert
(2024)
Open Access | Times Cited: 1
David G. Standaert
(2024)
Open Access | Times Cited: 1
Peripheral immune profile in drug-naïve dementia with Lewy bodies
Tadashi Umehara, Masahiro Mimori, Tatsushi Kokubu, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 4146-4157
Closed Access | Times Cited: 1
Tadashi Umehara, Masahiro Mimori, Tatsushi Kokubu, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 4146-4157
Closed Access | Times Cited: 1
Inflammatory Hematological Ratios in Adolescents with Mental Disorders: A Scoping Review
M. Yu. Popov, Y. V. Popov, D. N. Kosterin, et al.
Consortium Psychiatricum (2024) Vol. 5, Iss. 2, pp. 45-61
Open Access | Times Cited: 1
M. Yu. Popov, Y. V. Popov, D. N. Kosterin, et al.
Consortium Psychiatricum (2024) Vol. 5, Iss. 2, pp. 45-61
Open Access | Times Cited: 1
Biomarkers and Rehabilitation for Functional Neurological Disorder
Victor W. Mark
(2024)
Open Access | Times Cited: 1
Victor W. Mark
(2024)
Open Access | Times Cited: 1
From Diagnosis to Treatment: A Comprehensive Review of Biomarkers and Therapeutic Advances in Parkinson’s Disease
Hussain Sohail Rangwala, Hareer Fatima, Aina Marzia Syed, et al.
Annals of Neurosciences (2023) Vol. 32, Iss. 1, pp. 51-57
Open Access | Times Cited: 3
Hussain Sohail Rangwala, Hareer Fatima, Aina Marzia Syed, et al.
Annals of Neurosciences (2023) Vol. 32, Iss. 1, pp. 51-57
Open Access | Times Cited: 3
Exploring [11C]CPPC as a CSF1R-targeted PET Imaging Marker for Early Parkinson’s Disease Severity
Kelly A. Mills, Yong Du, Jennifer M. Coughlin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Kelly A. Mills, Yong Du, Jennifer M. Coughlin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
Qing He, Shuzhen Zhang, Jian Wang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7046-7065
Closed Access
Qing He, Shuzhen Zhang, Jian Wang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7046-7065
Closed Access
